JP2001039979A - PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE - Google Patents

PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE

Info

Publication number
JP2001039979A
JP2001039979A JP11213569A JP21356999A JP2001039979A JP 2001039979 A JP2001039979 A JP 2001039979A JP 11213569 A JP11213569 A JP 11213569A JP 21356999 A JP21356999 A JP 21356999A JP 2001039979 A JP2001039979 A JP 2001039979A
Authority
JP
Japan
Prior art keywords
group
pyridine
octahydropyrrolo
hydroborate
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11213569A
Other languages
Japanese (ja)
Inventor
Yasuhisa Kanda
泰寿 神田
Osamu Uno
修 宇野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koei Chemical Co Ltd
Original Assignee
Koei Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koei Chemical Co Ltd filed Critical Koei Chemical Co Ltd
Priority to JP11213569A priority Critical patent/JP2001039979A/en
Publication of JP2001039979A publication Critical patent/JP2001039979A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain, in high yield, the subject compound useful as an intermediate for medicines, by reducing a specific dioxoctahydropyrrolopyridine using a hydroborate salt in the presence of a specific halide. SOLUTION: This compound of formula II (e.g. 6-benzyloctahydropyrrolo[3,4- b]pyridine) is obtained by reducing a 5,7-dioxoctahydropyrrolo[3,4-b]pyridine of formula I (R1 to R3 are each H or a lower alkyl; and R4 is an aralkyl) (e.g. 6-benzyl-5,7-dioxoctahydropyrrolo[3,4-b]pyridine), normally in a solvent such as tetrahydrofuran, in the presence of a halide of at least one kind of a metal element selected from 3-14 group elements (except platinum group elements) (e.g. aluminum chloride), using a hydroborate such as sodium borohydride at preferably 0 to 40 deg.C, for, in general, about 1 to 5 h.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、オクタヒドロピロ
ロ[3,4−b]ピリジンの製造方法に関する。
TECHNICAL FIELD The present invention relates to a method for producing octahydropyrrolo [3,4-b] pyridine.

【0002】[0002]

【従来の技術】一般式(2):2. Description of the Related Art General formula (2):

【0003】[0003]

【化3】 Embedded image

【0004】[式中、R1、R2及びR3は、同一又は異
なってそれぞれ水素原子又は低級アルキル基を示す。R
4はアラルキル基を示す。]で表されるオクタヒドロピ
ロロ[3,4−b]ピリジンは、医薬の中間体として有
用な化合物である。
[Wherein, R 1 , R 2 and R 3 are the same or different and each represent a hydrogen atom or a lower alkyl group. R
4 represents an aralkyl group. The octahydropyrrolo [3,4-b] pyridine represented by the formula [1] is a compound useful as a pharmaceutical intermediate.

【0005】従来、一般式(2)で表されるオクタヒド
ロピロロ[3,4−b]ピリジンの製造法としては、例
えば特開平2−69474号公報に記載されている方法
が知られている。この公報に記載の方法は、6−ベンジ
ル−5,7−ジオキソオクタヒドロピロロ[3,4−
b]ピリジンを、水素化アルミニウムリチウムや水素化
ホウ素ナトリウムで還元して、6−ベンジル−オクタヒ
ドロピロロ[3,4−b]ピリジンを製造する方法であ
る。例えば、上記該公報の実施例では、無水テトラヒド
ロフラン中、水素化アルミニウムリチウムを用いて、6
−ベンジル−5,7−ジオキソオクタヒドロピロロ
[3,4−b]ピリジンを還元して、6−ベンジル−オ
クタヒドロピロロ[3,4−b]ピリジンを製造してい
るが、その収率は62.8%に過ぎない。上記公報には
水素化ホウ素ナトリウムを還元剤として用いた具体例は
ないが、本発明者の研究によれば、水素化ホウ素ナトリ
ウムを還元剤として用いた場合には、好ましくない副反
応が進行し、目的とする6−ベンジル−オクタヒドロピ
ロロ[3,4−b]ピリジンが全く生成しないことが判
明した(後記比較例1参照)。
Conventionally, as a method for producing octahydropyrrolo [3,4-b] pyridine represented by the general formula (2), for example, a method described in JP-A-2-69474 is known. . The method described in this publication discloses 6-benzyl-5,7-dioxooctahydropyrrolo [3,4-
b] Pyridine is reduced with lithium aluminum hydride or sodium borohydride to produce 6-benzyl-octahydropyrrolo [3,4-b] pyridine. For example, in the examples of the above-mentioned publication, lithium aluminum hydride in anhydrous tetrahydrofuran is used to form 6
-Benzyl-5,7-dioxooctahydropyrrolo [3,4-b] pyridine is reduced to produce 6-benzyl-octahydropyrrolo [3,4-b] pyridine. Is only 62.8%. Although there is no specific example in the above publication using sodium borohydride as a reducing agent, according to the study of the present inventors, when sodium borohydride is used as a reducing agent, an undesired side reaction proceeds. It was found that the desired 6-benzyl-octahydropyrrolo [3,4-b] pyridine was not formed at all (see Comparative Example 1 described later).

【0006】[0006]

【発明が解決しようとする課題】本発明は、一般式
(1):
SUMMARY OF THE INVENTION The present invention provides a compound represented by the general formula (1):

【0007】[0007]

【化4】 Embedded image

【0008】[式中、R1、R2、R3及びR4は前記に同
じ。]で表される5,7−ジオキソオクタヒドロピロロ
[3,4−b]ピリジンから一般式(2)のオクタヒド
ロピロロ[3,4−b]ピリジンをより一層高収率で製
造し得る方法を提供することを課題とする。
Wherein R 1 , R 2 , R 3 and R 4 are as defined above. Octahydropyrrolo [3,4-b] pyridine of the general formula (2) can be produced in higher yield from the 5,7-dioxooctahydropyrrolo [3,4-b] pyridine represented by the formula: It is an object to provide a method.

【0009】[0009]

【課題を解決するための手段】本発明者は、一般式
(2)のオクタヒドロピロロ[3,4−b]ピリジンを
より一層高収率で製造し得る方法を開発すべく、鋭意研
究を重ねてきた。その結果、一般式(1)の5,7−ジ
オキソオクタヒドロピロロ[3,4−b]ピリジンを、
水素化ホウ素ナトリウムで還元して、一般式(2)のオ
クタヒドロピロロ[3,4−b]ピリジンを製造するに
当たり、反応系内に水素化ホウ素ナトリウムと共に周期
律表第3〜14族元素(但し白金族元素を除く)からな
る群より選ばれる少なくとも1種の金属元素のハロゲン
化物を共存させた場合には、副反応を伴うことなく還元
反応が良好に進行して、目的とする一般式(2)のオク
タヒドロピロロ[3,4−b]ピリジンが高収率で製造
できることを見い出した。本発明は、斯かる知見に基づ
き完成されたものである。
Means for Solving the Problems The present inventors have made intensive studies to develop a method capable of producing octahydropyrrolo [3,4-b] pyridine of the general formula (2) in higher yield. I have piled up. As a result, 5,7-dioxooctahydropyrrolo [3,4-b] pyridine of the general formula (1)
In producing octahydropyrrolo [3,4-b] pyridine of the general formula (2) by reduction with sodium borohydride, an element belonging to Groups 3 to 14 of the periodic table together with sodium borohydride in the reaction system ( However, when a halide of at least one metal element selected from the group consisting of platinum group elements) is present, the reduction reaction proceeds favorably without side reactions, and the desired general formula It has been found that octahydropyrrolo [3,4-b] pyridine (2) can be produced in high yield. The present invention has been completed based on such findings.

【0010】即ち、本発明は、一般式(1)の5,7−
ジオキソオクタヒドロピロロ[3,4−b]ピリジン
を、周期律表第3〜14族元素(但し白金族元素を除
く)からなる群より選ばれる少なくとも1種の金属元素
のハロゲン化物の存在下、ヒドロホウ酸塩を用いて還元
して、一般式(2)のオクタヒドロピロロ[3,4−
b]ピリジンを得ることを特徴とするオクタヒドロピロ
ロ[3,4−b]ピリジンの製造方法に係る。
That is, the present invention relates to a compound represented by the general formula (1):
Dioxooctahydropyrrolo [3,4-b] pyridine in the presence of a halide of at least one metal element selected from the group consisting of elements from Groups 3 to 14 of the periodic table (excluding platinum group elements) Is reduced using a hydroborate to give the octahydropyrrolo [3,4-
The present invention relates to a method for producing octahydropyrrolo [3,4-b] pyridine, which comprises obtaining b] pyridine.

【0011】本発明によれば、一般式(1)の5,7−
ジオキソオクタヒドロピロロ[3,4−b]ピリジンか
ら一般式(2)のオクタヒドロピロロ[3,4−b]ピ
リジンをより一層高収率で製造し得る。
According to the present invention, 5,7-
Octahydropyrrolo [3,4-b] pyridine of the general formula (2) can be produced from dioxooctahydropyrrolo [3,4-b] pyridine in even higher yield.

【0012】[0012]

【発明の実施の形態】上記一般式(1)及び一般式
(2)において、R1、R2及びR3で示される低級アル
キル基としては、例えばメチル基、エチル基、n−プロ
ピル基、イソプロピル基、n−ブチル基、イソブチル
基、tert−ブチル基等の直鎖又は分枝鎖状の炭素数
1〜4のアルキル基を挙げることができ、好ましくはメ
チル基、エチル基等を例示できる。
BEST MODE FOR CARRYING OUT THE INVENTION In the above general formulas (1) and (2), the lower alkyl groups represented by R 1 , R 2 and R 3 include, for example, methyl, ethyl, n-propyl, Examples thereof include linear or branched alkyl groups having 1 to 4 carbon atoms such as an isopropyl group, an n-butyl group, an isobutyl group, and a tert-butyl group, and preferably a methyl group and an ethyl group. .

【0013】また、R4で示されるアラルキル基として
は、例えばベンジル基、フェネチル基等が挙げられ、こ
れらのベンゼン環上には低級アルキル基(メチル基、エ
チル基、n−プロピル基、イソプロピル基、n−ブチル
基等の炭素数1〜4のアルキル基、好ましくはメチル基
及びエチル基)、低級アルコキシ基(メトキシ基、エト
キシ基、n−プロポキシ基、イソプロポキシ基、n−ブ
トキシ基等の炭素数1〜4のアルコキシ基、好ましくは
メトキシ基及びエトキシ基)及びハロゲン原子(フッ素
原子、塩素原子及び臭素原子)からなる群より選ばれる
少なくとも1個の置換基が置換していてもよい。R4
示されるアラルキル基としては、ベンゼン環上に低級ア
ルキル基を1個以上、特に1〜2個有していてもよいベ
ンジル基が好ましい。
The aralkyl group represented by R 4 includes, for example, a benzyl group and a phenethyl group, and a lower alkyl group (a methyl group, an ethyl group, an n-propyl group, an isopropyl group) , An alkyl group having 1 to 4 carbon atoms such as an n-butyl group, preferably a methyl group and an ethyl group), a lower alkoxy group (a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, an n-butoxy group, etc.). At least one substituent selected from the group consisting of an alkoxy group having 1 to 4 carbon atoms, preferably a methoxy group and an ethoxy group) and a halogen atom (a fluorine atom, a chlorine atom and a bromine atom) may be substituted. As the aralkyl group represented by R 4 , a benzyl group which may have one or more lower alkyl groups on the benzene ring, particularly one or two lower alkyl groups is preferable.

【0014】ヒドロホウ酸塩としては、従来公知のもの
を広く使用でき、例えば水素化ホウ素リチウム、水素化
ホウ素ナトリウム、水素化ホウ素カリウム、水素化ホウ
素亜鉛及びシアン化水素化ホウ素ナトリウム等を挙げる
ことができる。これらの中でも、水素化ホウ素リチウ
ム、水素化ホウ素ナトリウム及び水素化ホウ素カリウム
等の水素化ホウ素アルカリが好ましく、水素化ホウ素ナ
トリウムが特に好ましい。
As the hydroborate, conventionally known ones can be widely used, and examples thereof include lithium borohydride, sodium borohydride, potassium borohydride, zinc borohydride, and sodium cyanoborohydride. Among them, alkali borohydrides such as lithium borohydride, sodium borohydride and potassium borohydride are preferable, and sodium borohydride is particularly preferable.

【0015】ヒドロホウ酸塩の使用量としては、特に制
限されるものではないが、一般式(1)の5,7−ジオ
キソオクタヒドロピロロ[3,4−b]ピリジン1モル
に対して2モル(理論量)以上、好ましくは2.5モル
〜7モル、特に好ましくは3モル〜5モルとするのがよ
い。
The amount of the hydroborate used is not particularly limited, but may be 2 to 1 mol of 5,7-dioxooctahydropyrrolo [3,4-b] pyridine of the general formula (1). It is good to be more than mol (theoretical amount), preferably 2.5 mol to 7 mol, particularly preferably 3 mol to 5 mol.

【0016】本発明においては、反応系内に周期律表第
3〜14族元素(但し白金族元素を除く)からなる群よ
り選ばれる少なくとも1種の金属元素のハロゲン化物を
存在させる。斯かる金属元素のハロゲン化物は、好まし
くはイットリウム及びランタノイド元素(ランタン、セ
リウム等)等の第3族、チタン及びジルコニウム等の第
4族、鉄等の第8族、コバルト等の第9族、亜鉛等の第
12族、アルミニウム及びガリウム等の第13族並びに
スズ等の第14族の金属元素の塩化物等を挙げることが
でき、より好ましくは塩化アルミニウム(III)、塩化
鉄(III)、塩化スズ(IV)、塩化ガリウム(III)等を
挙げることができる。
In the present invention, a halide of at least one metal element selected from the group consisting of elements of Groups 3 to 14 of the periodic table (excluding platinum group elements) is present in the reaction system. The halides of such metal elements are preferably Group 3 such as yttrium and lanthanoid elements (lanthanum, cerium, etc.), Group 4 such as titanium and zirconium, Group 8 such as iron, Group 9 such as cobalt, Examples thereof include chlorides of metal elements belonging to Group 12 such as zinc, Group 13 such as aluminum and gallium, and Group 14 such as tin, and more preferably aluminum (III) chloride, iron (III) chloride, and the like. Tin (IV) chloride, gallium (III) chloride and the like can be mentioned.

【0017】上記金属元素のハロゲン化物の使用量とし
ては、用いられるヒドロホウ酸塩の種類等により異なり
一概に言えるものではないが、通常ヒドロホウ酸塩1モ
ルに対して上記金属元素のハロゲン化物を1/4モル〜
1モル、好ましくは1/3モル〜1/2モル用いるのが
よい。
The amount of the metal element halide used depends on the type of the hydroborate used and cannot be said unconditionally. However, the amount of the metal element halide is usually 1 mol per mol of the hydroborate. / 4mol ~
1 mol, preferably 1/3 mol to 1/2 mol, is used.

【0018】本発明の還元反応は、通常溶媒中で行われ
る。溶媒としては、反応に悪影響を及ぼさない限り従来
公知のものを広く使用できるが、テトラヒドロフラン、
ジエチレングリコールジメチルエーテル等のエーテル類
が特に好ましい。
The reduction reaction of the present invention is usually performed in a solvent. As the solvent, conventionally known solvents can be widely used as long as they do not adversely affect the reaction.
Ethers such as diethylene glycol dimethyl ether are particularly preferred.

【0019】本発明の還元反応は、室温下、冷却下及び
加温下のいずれでも進行するが、通常0℃〜使用される
溶媒の沸点、好ましくは0〜40℃で反応を行うのがよ
い。反応時間は、一般に1〜5時間程度である。
The reduction reaction of the present invention proceeds at room temperature, under cooling and under heating, but the reaction is usually carried out at 0 ° C. to the boiling point of the solvent used, preferably at 0 to 40 ° C. . The reaction time is generally about 1 to 5 hours.

【0020】上記反応終了後、目的とする一般式(2)
のオクタヒドロピロロ[3,4−b]ピリジンは、従来
公知の単離精製手段に従い、反応混合物から容易に単
離、精製される。
After completion of the above reaction, the desired compound of the general formula (2)
Of octahydropyrrolo [3,4-b] pyridine is easily isolated and purified from the reaction mixture according to a conventionally known isolation and purification means.

【0021】[0021]

【実施例】以下に実施例を掲げて、本発明をより一層明
らかにする。
The present invention will be further clarified with reference to the following examples.

【0022】実施例1 容量500mlの4つ口フラスコにテトラヒドロフラン
56gを仕込み、0℃に冷却しながら無水塩化アルミニ
ウム5.6g(42ミリモル)を溶解した。得られた溶
液に、攪拌下、6−ベンジル−5,7−ジオキソオクタ
ヒドロピロロ[3,4−b]ピリジン6.1g(25ミ
リモル)をテトラヒドロフラン61gに溶解した溶液を
滴下し、次いで水素化ホウ素ナトリウム4.7g(12
5ミリモル)を投入し、室温で5時間反応を行った。反
応終了後、得られた反応液に10重量%水酸化ナトリウ
ム水溶液を発泡に注意しながら滴下して混合して、過剰
の水素化ホウ素ナトリウム及び塩化アルミニウムを分解
した後、トルエンを加えて抽出した。水層と有機層を分
離し、有機層を500mlの4つ口フラスコに仕込み、
5重量%塩酸50mlを加え、還流下に5時間攪拌し
た。冷却後、水層と有機層を分離した。得られた水層に
48重量%水酸化ナトリウム水溶液を加えて、pH14
に調整した後、トルエン50mlによる抽出を3回行っ
た。得られたトルエン層を合わせてトルエンを除去して
濃縮した後、蒸留して6−ベンジル−オクタヒドロピロ
ロ[3,4−b]ピリジン4.6g(収率85%)を得
た。
Example 1 A 500-ml four-necked flask was charged with 56 g of tetrahydrofuran, and 5.6 g (42 mmol) of anhydrous aluminum chloride was dissolved while cooling to 0 ° C. To the resulting solution, a solution of 6.1 g (25 mmol) of 6-benzyl-5,7-dioxooctahydropyrrolo [3,4-b] pyridine dissolved in 61 g of tetrahydrofuran was added dropwise with stirring, and then hydrogen was added. 4.7 g of sodium borohydride (12
(5 mmol) and reacted at room temperature for 5 hours. After completion of the reaction, a 10% by weight aqueous solution of sodium hydroxide was added dropwise to the obtained reaction solution while paying attention to foaming, mixed to decompose excess sodium borohydride and aluminum chloride, and extracted with toluene. . Separate the aqueous layer and the organic layer, charge the organic layer in a 500 ml four-necked flask,
50 ml of 5% by weight hydrochloric acid was added, and the mixture was stirred under reflux for 5 hours. After cooling, an aqueous layer and an organic layer were separated. A 48% by weight aqueous sodium hydroxide solution was added to the obtained aqueous layer to adjust the pH to 14%.
Then, extraction with 50 ml of toluene was performed three times. The resulting toluene layers were combined, toluene was removed, concentrated, and distilled to obtain 4.6 g of 6-benzyl-octahydropyrrolo [3,4-b] pyridine (yield: 85%).

【0023】比較例1 実施例1において無水塩化アルミニウムを使用しない以
外は実施例1と同様に反応を行った。得られた反応液を
ガスクロマトグラフィーにより分析した結果、6−ベン
ジル−オクタヒドロピロロ[3,4−b]ピリジンの生
成は認められなかった。反応液には、原料化合物である
6−ベンジル−5,7−ジオキソオクタヒドロピロロ
[3,4−b]ピリジンが約半分残存しており、残りは
原料化合物の各種部分還元物の混合物であった。
Comparative Example 1 A reaction was carried out in the same manner as in Example 1 except that anhydrous aluminum chloride was not used. As a result of analyzing the obtained reaction solution by gas chromatography, formation of 6-benzyl-octahydropyrrolo [3,4-b] pyridine was not observed. Approximately half of 6-benzyl-5,7-dioxooctahydropyrrolo [3,4-b] pyridine as the starting compound remains in the reaction solution, and the remainder is a mixture of various partially reduced products of the starting compound. there were.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C065 AA04 BB04 CC01 DD02 HH01 HH02 JJ01 KK09 LL01 LL04 PP03 QQ03 4H039 CA40 CB40  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C065 AA04 BB04 CC01 DD02 HH01 HH02 JJ01 KK09 LL01 LL04 PP03 QQ03 4H039 CA40 CB40

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1): 【化1】 [式中、R1、R2及びR3は、同一又は異なってそれぞ
れ水素原子又は低級アルキル基を示す。R4はアラルキ
ル基を示す。]で表される5,7−ジオキソオクタヒド
ロピロロ[3,4−b]ピリジンを、周期律表第3〜1
4族元素(但し白金族元素を除く)からなる群より選ば
れる少なくとも1種の金属元素のハロゲン化物の存在
下、ヒドロホウ酸塩を用いて還元して、一般式(2): 【化2】 [式中、R1、R2、R3及びR4は前記に同じ。]で表さ
れるオクタヒドロピロロ[3,4−b]ピリジンを得る
ことを特徴とするオクタヒドロピロロ[3,4−b]ピ
リジンの製造方法。
1. General formula (1): [Wherein, R 1 , R 2 and R 3 are the same or different and each represent a hydrogen atom or a lower alkyl group. R 4 represents an aralkyl group. ] Is represented by the following formula: 3-1.
Reduction with a hydroborate in the presence of a halide of at least one metal element selected from the group consisting of Group 4 elements (excluding the platinum group elements) is carried out using a hydroborate to give a compound of the general formula (2): Wherein R 1 , R 2 , R 3 and R 4 are the same as above. Octahydropyrrolo [3,4-b] pyridine represented by the following formula:
JP11213569A 1999-07-28 1999-07-28 PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE Pending JP2001039979A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11213569A JP2001039979A (en) 1999-07-28 1999-07-28 PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11213569A JP2001039979A (en) 1999-07-28 1999-07-28 PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE

Publications (1)

Publication Number Publication Date
JP2001039979A true JP2001039979A (en) 2001-02-13

Family

ID=16641389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11213569A Pending JP2001039979A (en) 1999-07-28 1999-07-28 PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE

Country Status (1)

Country Link
JP (1) JP2001039979A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675308A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing 8-benzyl-2,8-diazabicyclo(4.3.0) nonane
CN102675307A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing chiral compound 8-phenethyl-2,8-diazabicyclo[4.3.0]nonane
WO2012131629A1 (en) * 2011-03-31 2012-10-04 Piramal Healthcare Limited A process for preparation of intermediate of moxifloxacin
WO2014097272A2 (en) 2012-12-21 2014-06-26 Mankind Research Centre Method for production of (s,s)-6-benzyloctahydro-1h-pyrrolo[3,4-b]pyridine, an intermediate of azabicyclo pyridine derivatives
CN104163820A (en) * 2014-01-13 2014-11-26 江苏永达药业有限公司 Preparation method of moxifloxacin intermediate compound
CN105418606A (en) * 2015-11-24 2016-03-23 浙江省诸暨合力化学对外贸易有限公司 Preparation method for 8-benzyl-2,8-diazabicyclo[4.3.0]-nonane
CN112028818A (en) * 2020-09-26 2020-12-04 安徽金禾实业股份有限公司 Method for recovering catalyst pyridine

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675308A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing 8-benzyl-2,8-diazabicyclo(4.3.0) nonane
CN102675307A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing chiral compound 8-phenethyl-2,8-diazabicyclo[4.3.0]nonane
WO2012131629A1 (en) * 2011-03-31 2012-10-04 Piramal Healthcare Limited A process for preparation of intermediate of moxifloxacin
WO2014097272A2 (en) 2012-12-21 2014-06-26 Mankind Research Centre Method for production of (s,s)-6-benzyloctahydro-1h-pyrrolo[3,4-b]pyridine, an intermediate of azabicyclo pyridine derivatives
CN104163820A (en) * 2014-01-13 2014-11-26 江苏永达药业有限公司 Preparation method of moxifloxacin intermediate compound
CN105418606A (en) * 2015-11-24 2016-03-23 浙江省诸暨合力化学对外贸易有限公司 Preparation method for 8-benzyl-2,8-diazabicyclo[4.3.0]-nonane
CN112028818A (en) * 2020-09-26 2020-12-04 安徽金禾实业股份有限公司 Method for recovering catalyst pyridine

Similar Documents

Publication Publication Date Title
US6156925A (en) Process for the preparation of halogenated phenylmaloates
CN104876956B (en) The technique of one pot process boron aminated compounds
JP2001039979A (en) PRODUCTION OF OCTAHYDROPYRROLO[3,4-b]PYRIDINE
JP2000026418A (en) New production of derivative of 4-phenyl-1,2,3,6- tetrahydropyridine and intermediate used therefor
CN108484488B (en) Method for synthesizing 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde by photo/nickel concerted catalysis
US20040038940A1 (en) Processes for preparing substituted aryl boronic acids
JP2013095752A (en) Process for preparation of 2-alkoxy-5-(pyridin-2-yl)pyridine as intermediate of perampanel
EP1002788B1 (en) Process for preparing halogenated phenylmalonates
EP1506963A1 (en) Method for the preparation of citalopram
JP3671281B2 (en) Method for producing trimethylsilyl azide
JP4523093B2 (en) Process for producing 2-amino-bromopyrazines
CN114213373B (en) Synthesis method of dibenzofuran derivative
US6489526B2 (en) Method for synthesis of hydrocarbyl bridged indenes
JPH04169583A (en) Phenothiazine derivative and its production
JP2002179612A (en) Method for producing 2,3-dibromosuccinic acid compound
JP3751713B2 (en) Method for producing triarylborane phosphine complex
JP4344422B2 (en) Method for producing p-bromophenols
JP4663105B2 (en) Method for producing 2-sulfonyl-4-oxypyridine derivative
JP2706554B2 (en) 4-trifluoromethylaniline derivative and method for producing the same
JP2004155659A (en) Method for producing 9-spirofluorene compound
JP2002088092A (en) New organometallic complex and method for synthesizing highly pure organometallic complex using the same as intermediate
TW393483B (en) Process for the preparation of dihaloazolopyrimidines
JP2500135B2 (en) Method for producing catechol
JPH06247915A (en) Production of acetamide derivative
JP2946678B2 (en) Chiral ferrocene derivatives